Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q2 EPS by 13c, Revenues Miss
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $84.95 -0.75%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of ($0.26), $0.13 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $32.81 million versus the consensus estimate of $37.7 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
